Mediterranean studies of cardiovascular disease and hyperglycemia: Analytical modeling of population socio-economic transitions (MedCHAMPS)-rationale and methods

International Journal of Public Health

Volumn 58, Issue 4, 2013, Pages 547-553

  Maziak, Wasim ^a,b   Critchley, Julia ^c,d   Zaman, Shahaduz ^d   Unwin, Nigel ^e   Capewell, Simon ^f   Bennett, Kathleen ^g   Unal, Belgin ^h   Husseini, Abdullatif ⁱ   Romdhane, Habiba Ben ^j   Phillimore, Peter ^d  

^a SYRIAN CENTER FOR TOBACCO STUDIES   (Syrian Arab Republic)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF THE WEST INDIES   (Jamaica)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g TRINITY COLLEGE DUBLIN   (Ireland)

^h DOKUZ EYLUL UNIVERSITY   (Turkey)

ⁱ BIRZEIT UNIVERSITY   (Palestine)

^j UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

more..

Author keywords

Cardiovascular disease; Diabetes; Interventions; Mediterranean Region; Policies; Population; Trends

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COOPERATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; HYPERGLYCEMIA; IRELAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; SOUTHERN EUROPE; STATISTICAL MODEL; STATISTICS; SYRIAN ARAB REPUBLIC; TUNISIA; TURKEY (REPUBLIC); UNITED KINGDOM; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; STATISTICS AND NUMERICAL DATA; TURKEY;

CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; GREAT BRITAIN; HUMANS; HYPERGLYCEMIA; IRELAND; MEDITERRANEAN REGION; MODELS, STATISTICAL; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SYRIA; TUNISIA; TURKEY;

EID: 84880922281     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-012-0423-4     Document Type: Article

References (25)

1. Alwan AA (1993) Cardiovascular diseases in the eastern Mediterranean region. World Health Stat Q 46(2):97-100
2. Beaglehole R, Yach D (2003) Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 362(9387):903-908
3. Capewell S, Beaglehole R, Seddon M, McMurray J (2000) Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 102(13):1511-1516
4. Critchley J, Liu J, Zhao D, Wei W, Capewell S (2004) Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 110(10):1236-1244
5. Ebrahim S, Smith GD (2001) Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol 30(2):201-205
6. Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ (2005) Rethinking the diseases of affluence paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2(5):e133
7. Ford E, Ajani U, Croft J, Critchley JA, Labarthe D, Kottke T (2007) Explaining the decrease in mortality from coronary heart disease in the United States between 1980 and 2000. N Engl J Med 356:2388-2398
8. International Diabetes Federation 2011, Diabetes Atlas. (http://www.idf.org/atlasmap/atlasmap). Accessed 16 Nov 2011
9. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S (2005) Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162(8):764-773
10. Maziak W (2006) Health in the middle East. BMJ 333(7573):815-816
11. Maziak W (2009) The crisis of health in a crisis ridden region. Int J Public Health 54(5):349-355
12. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U (2007) Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol 17(9):713-720
13. Murray CJ, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard Univ Press, Boston
14. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study. Lancet 349(9064):1498-1504
15. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361(9359):717-725
16. Nugent R (2008) Chronic diseases in developing countries: health and economic burdens. Ann N Y Acad Sci 1136:70-79
17. Reddy KS (2002) Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 5(1A):231-237
18. Rodgers A, Vaughan P (2002) 'World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization, Geneva
19. Rose G (1985) Sick individuals and sick populations. Int J Epidemiol 14(1):32-38
20. Unal B, Critchley JA, Capewell S (2004) Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109(9):1101-1107
21. World health Organization (1999) The world health report 1999: making a difference. WHO, Geneva
22. World Health Organization 2011a, Diabetes Programme. [ http://www.who.int/diabetes/en/ ]. Accessed 2 Dec 2011
23. World Health Organization 2011b, 'Obesity and overweight. Fact sheets. Available at: [ http://www.who.int/mediacentre/factsheets/fs311/en/ ] Accessed 2 Dec 2011
24. Yach D, Leeder SR, Bell J, Kistnasamy B (2005) Global chronic diseases. Science 307(5708):317
25. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22):2746-2753